April 28, 2016 – San Diego, CA – Dotcom career services companies Postings.com and Job.com have joined forces to provide an even more efficient and cost effective way to advertise job openings. Now small to medium sized businesses will reach Job.com and its network of job boards through Postings.com’s job distribution software. Clients can save up to 60% on their recruiting efforts by using Postings.com and its proprietary job distribution algorithm.

Formerly Catalyst 5, Postings.com was founded in 2005 by CEO Mike O’Brien, as part of the Mingle LLC group based in San Diego, CA. The cloud based software platform enables users to post job ads that are then automatically distributed to the job boards and social media outlets where similar job ads have succeeded. Each posting is individually tailored and monitored for efficiency, so clients do not waste time and money advertising on job sites that have historically delivered no or low qualified candidates.

“We are very excited to add Job.com as a key distribution partner,” said Mike O’Brien, Postings.com CEO, “they are simply one of the best, high quality candidates sources on the Internet.”

Job.com is a part of the Virginia Web Properties family, with headquarters in Fredricksbug, VA. Brian Alden, Virginia Web Properties CEO, added, “We are extremely happy to work with Postings.com and to deliver our job seekers additional job content from Small and Mid Market companies.”

Job.com is one of the fastest growing career portals on the Internet. The company and its larger job board network has strong relationships with candidates in the healthcare industry, information technology, retail, transportation, sales and hospitality industries.

Together Postings.com and Job.com are working to improve job content distribution for both candidates and those people who are interested in hiring them.

About Postings.com

Postings.com is a cloud based software as a solution platform that enables companies and recruiters to greatly improve their recruiting programs and lower costs associated with job advertising. Postings.com streamlines the process of sourcing candidates while reducing front office recruiter workload, allowing them to focus on higher value activities. Candidate’s resumes are automatically imported and parsed into searchable digital files. With a few clicks, create targeted emails and text campaigns to imported candidates and/or access a growing database of 4 million candidates

Job.com, headquartered in Fredericksburg, VA, is an online, full-service career portal offering over three million jobs across its network of over 150 industry- and regionally-focused career sites. Job.com specializes in helping employers and recruiters hire qualified employees, while providing job seekers with a variety of career- and job search-enhancing services, and products. With over 43 million registered members, Job.com’s candidates represent every state in the U.S. and come from 70 different disciplines ranging from IT to Sales to Executive Management. Whether you are an employer looking for a new hire, or a candidate looking to be hired, Job.com is dedicated to providing a unique experience with unparalleled service.

GET IN TOUCH
Mike O’Brien
Postings.com
619-618-4201
http://www.postings.com

Release ID: 245732

April 28, 2016 – – LegalHerald.com reports on the verdicts of two Risperdal lawsuits which resulted in plaintiffs being awarded millions. The defendant, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), has been found liable in the case of a young man who grew large breasts after taking the drug (a condition known as gynecomastia) and been found responsible for marketing fraud in another lawsuit filed by the state of South Carolina.

The first case took place in Philadelphia, where the jury awarded the plaintiff and his family $2.5 million after they claimed that Risperdal, a powerful antipsychotic drug, caused him to develop gynecomastia, or male breast growth. The now 20-year-old began taking the drug “off-label” at the age of 8 to treat symptoms of autism, and from that time developed size 46DD breasts. In his suit, the plaintiff claimed that the manufacturers failed to properly inform consumers and medical professionals of the potential side effects that could occur when taking the drug.

“Off-label” marketing is a very controversial tactic at the center of many lawsuits involving Risperdal. If a drug is prescribed “off-label” it means that it is being prescribed in a way that has not been approved by the FDA. This case was not the first time Janssen has been in legal trouble with regard to their marketing tactics. In 2013, Johnson & Johnson paid $2.2 billion to settle off-label marketing claims for several drugs including Risperdal. Those claims were brought against the company by the U.S. Department of Justice and several states.

The second Risperdal lawsuit was filed by the state of South Carolina in 2007. The complaint alleged that the pharmaceutical company illegally marketed their drug by sending out over 7,000 letters to doctors which downplayed the side effects of Risperdal and embellished its benefits. They were ordered to pay $4,000 per letter that was sent out. The original jury verdict instructed the company to pay $327 million but this amount was later reduced by Judge Kittredge to $136 million.

The attorneys at Banville Law understand how concerning the recent news regarding Risperdal can be for individuals who have taken the drug. The firm is working to ensure that anyone who has used the drug and who has suffered from adverse health events that they attribute to its use will have the opportunity to explore their legal options. Banville Law is currently offering complimentary consultations for affected parties who could be entitled to substantial compensation.

For more information on Risperdal lawsuits, or to ask questions, contact the attorneys of Banville Law by calling (888) 997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60009651

April 28, 2016 – – TheProductLawyers.com reports on a lawsuit which was filed in early 2016 by a plaintiff from South Dakota. The complaint is filed against defendant C.R. Bard, and references an IVC filter device they manufacture. The company’s IVC Eclipse blood clot filter is mentioned in the lawsuit. The plaintiff indicates that the filter shattered into pieces within her body and migrated, becoming lodged within her internal organs.

IVC filters are medical devices used among patients who are at risk for the development of blood clots, but who are not able to use traditional blood-thinning drugs. The cage-like filters are surgically implanted into the inferior vena cava vein, and are designed to remain at that location and catch blood clots traveling toward the heart and lungs from the lower body, thus preventing them from causing pulmonary embolism or other significant events.

The filters are designed to hold the clots until they dissipate, and are intended to be used in patients temporarily and removed when the risk of pulmonary embolism subsides. Unfortunately, this plaintiff is not alone in her allegations, and the filters have been linked to dangerous and life-threatening side effects, as allegations from patients and plaintiffs across the United States continue to note that they are defectively designed.

This particular plaintiff filed her lawsuit with the U.S. District Court for the District of South Dakota, and indicated that the Bard Eclipse IVC filter was surgically implanted into her in October of 2012 as she was deemed at increased risk of blood clot formation at that time. The lawsuit has now been consolidated with others to form multidistrict litigation number 2641. The woman reports that she discovered later that her filter device had somehow broken loose and traveled from of its original location to become embedded within her organs, where it remains to this day.

The woman notes that she had attempted to have the filter surgically removed in January of 2014, however, the attempt was not successful, and surgeons informed her that the filter was in an area that was too risky for surgery. Because the device must now remain in her body, it is increasingly likely that the woman will face continued health problems from it; even potentially life-threatening ones, and she will need the help of long-term medical care.

The attorneys of Banville Law know well how alarming these lawsuit claims can be for patients currently implanted with various IVC filter brands. They are working to help other patients who have used or are currently using IVC filters and who believe that the devices have caused them to suffer from adverse health events. Affected patients may be entitled to substantial compensation, and are greatly encouraged to take the important opportunity to evaluate their legal rights in the matter. In order to better assist those who wish to investigate their legal options fully, the attorneys of Banville Law are also offering free legal consultations for affected individuals at this time.

To request further information, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009654

April 28, 2016 – – BloodThinnerHelp.com reports on the details of another lawsuit which was filed against Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation) referencing their new-generation blood-thinning drug Xarelto. The plaintiff in this case alleges that Xarelto use caused the death of her husband. The widow has filed a wrongful death suit which was initially listed under case number 9:14-cv-80831 in a Southern Florida court but was later transferred to the Eastern District of Louisiana to be consolidated with thousands of other similar lawsuits forming multidistrict litigation No. 2592. The MDL is being overseen at this time by the Honorable Judge Eldon Fallon.

Further details from within the lawsuit state that the widow claims that Xarelto manufacturers neglected to properly warn medical professionals and patients about potentially serious risks surrounding their product, such as sudden bleeding episodes and other adverse events she now connects to use of their product. The widow alleges that the anticoagulant caused her husband’s death, which happened when he suffered from an unexpected and uncontrollable internal bleeding event. Due to the Xarelto in his system, the woman reports, doctors were unable to clot his blood.

The woman goes on to explain that her husband was given a prescription for Xarelto as a treatment for his atrial fibrillation condition. The drug was intended to stop him from experiencing strokes, however, while the man was taking the drug, he instead suffered a subdural hemorrhage (or brain bleed), which caused him to ultimately pass away after doctors could not stop the bleed.

Unfortunately, this widow is not alone in her lawsuit claims. In just five year’s time, Xarelto has become the subject of over 3,400 lawsuits which have been formed into two main groupings. Over 2,800 federally-filed lawsuits have been transferred by the JPML to form MDL 2592 in Eastern Louisiana while more than 620 others have been formed into a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania. Involved plaintiffs share strikingly similar allegations that the drug places users at increased risk of severe and potentially life-threatening bleeding events.

As those involved anxiously await their day at trial, Attorney Joseph Osborne is working to help other patients who have used Xarelto and who believe the drug has negatively impacted their health. He hopes to ensure that all affected patients will be provided with the important opportunity to investigate their legal rights in the matter, as they may be entitled to significant compensation. To assist those wishing to further explore their options at this time, Attorney Osborne is offering complimentary legal consultations for qualified parties.

To request additional information, or to ask questions, contact Attorney Joseph Osborne at your convenience by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009653

April 28, 2016 – – TheProductLawyers.com reports on mesh material that has been at the center of thousands of lawsuits nationwide. Transvaginal mesh is usually made from synthetic polypropylene, defined as a thermoplastic polymer that has a variety of uses. According to an abstract published on Wiley Online Library written by Vladimir V. Iakovlev, Scott A. Guelcher and Robert Bendavid, mesh degradation is still widely debated and the abstract describes 164 excised meshes that were observed for features of degradation. According to the abstract, “Several features indicated that the degradation layer formed in vivo: inflammatory cells trapped within fissures, melting caused by cautery of excision surgery, and gradual but progressive growth of the degradation layer while in the body. Cracking of the degraded material indicated a contribution to clinically important mesh stiffening and deformation.”

The erosion of the mesh material has been a significant factor in many lawsuits that have been filed against manufacturers. Thousands of women who have had the mesh implanted have alleged that the mesh causes severe side effects that have altered their quality of life for the worse. Plaintiffs in these lawsuits have claimed to suffer from organ perforation, bleeding, severe pelvic or vaginal pain, urinary tract infections, recurrent prolapse or incontinence, inability to engage in sexual intercourse, fistulas, vaginal scarring, vaginal shrinkage, nerve damage and, in some cases, emotional problems.

The mesh was approved by the FDA in 1996 for procedures involving stress urinary incontinence and was later approved in 2002 for treatment of pelvic organ prolapse. Since then, thousands of adverse events related to the mesh have been reported to the FDA, prompting warnings and reclassifications for the devices as well as thousands of lawsuits against companies including C.R. Bard, Johnson & Johnson, Cook Medical, Boston Scientific and Coloplast Corp. There are currently over 70,000 cases filed in the U.S.

As these cases are expected to accumulate, lawyers at Banville Law are working to ensure that those individuals who have been treated with transvaginal mesh are able to explore their legal rights fully. Qualifying individuals may be entitled to legal action and substantial financial compensation. The firm is currently offering free case evaluations for interested parties.

For more information, or to ask questions about transvaginal mesh, contact Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009646

April 28, 2016 – – Santa Barbara Matchmaking is a new member of the nonprofit 1% for the Planet and is launching a new program called “Purpose and Passion.” 1% for the Planet is a global organization, which leads a network of businesses, nonprofits and individuals working together for a healthy planet. SB Matchmaking’s “Purpose and Passion” program is designed to create passion among like-minded individuals who want to support a clean and healthy environment.

This was done by joining forces with four other 1% for the Planet companies in Santa Barbara. SB Matchmaking has designed three unique dating experiences its clients can choose from:

-Wet and Wild — “This is a package for the adventurous. Do you like exploring new places right here in our backyard? Kayak the Channel Islands or rent a SUP from Channel Island Outfitters. Being active together is sure to be a great first date.”

-Fit and Fun — “Do you like to move your body and start your day off right? Connect with your date by taking a yoga class at Power of Your Om Yoga Studio followed by a trip to Juice Ranch to get a yummy organic juice.”

-Picnic in Paradise — “Are you a hopeless romantic? Experience a delicious picnic at our beautiful Botanic Gardens here in Santa Barbara, complete with an organic artisan picnic.”

And as a 1% FTP member, SB Matchmaking enjoys letting new clients choose which 1% FTP nonprofit organization they’d like to support. The local organizations they can choose from include the Santa Barbara Food Bank, Save the Mermaids, SB Bike Coalition, Channel Islands Restoration, Santa Barbara Foundation LEAF initiative, Organic Soup Kitchen, The Land Trust for Santa Barbara County and Heal the Ocean.

SB Matchmaking is committed to supporting Central Coast businesses that have the common goal of making this planet a better place to live.
“Becoming a member of 1% For the Planet has allowed us to connect with other like-minded companies and bring individuals together who want to be a part of something bigger than themselves,” said SB Matchmaking founder Lisa Amador. “Now, if that isn’t love, I don’t know what is!”

SB Matchmaking is a discreet upscale matchmaking and date coaching company for successful commitment-minded singles primarily in Central and Southern California.

“Our emphasis is on quality, not quantity and our approach is a personal one,” Amador said. “We form real relationships with our clients, taking the time to understand who they are on the deepest level. Nothing can replace the personal touch and we believe there is nothing more important than love.”

###

Contact Santa Barbara Matchmaking:

Lisa Amador
805-699-5650
lisa@sbmatchmaking.com
Santa Barbara, Ca.

ReleaseID: 60009652